Your browser doesn't support javascript.
loading
The role of aldosterone and ideal cardiovascular health in incident cardiovascular disease: The Jackson heart study.
Kluwe, Bjorn; Pohlman, Neal; Kesireddy, Veena; Zhao, Songzhu; Tan, Yubo; Kline, David; Brock, Guy; Odei, James B; Effoe, Valery S; Tcheugui, Justin B Echouffo; Kalyani, Rita R; Sims, Mario; Taylor, Herman A; Mongraw-Chaffin, Morgana; Akhabue, Ehimare; Joseph, Joshua J.
Afiliação
  • Kluwe B; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
  • Pohlman N; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
  • Kesireddy V; Division of Endocrinology, University Of Texas Medical Branch at Galveston, Galveston, Texas, United States.
  • Zhao S; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
  • Tan Y; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
  • Kline D; Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.
  • Brock G; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
  • Odei JB; Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.
  • Effoe VS; Division of Biostatistics, The Ohio State University College of Public Health, Columbus, Ohio, United States.
  • Tcheugui JBE; Division of Cardiology, Morehouse School of Medicine, Atlanta, Georgia, United States.
  • Kalyani RR; Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
  • Sims M; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, United States.
  • Taylor HA; Division of Cardiology, Morehouse School of Medicine, Atlanta, Georgia, United States.
  • Mongraw-Chaffin M; Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States.
  • Akhabue E; Division of Cardiovascular Diseases and Hypertension, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States.
  • Joseph JJ; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
Am J Prev Cardiol ; 14: 100494, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37114212
ABSTRACT

Background:

Higher levels of ideal cardiovascular health (ICH) are associated with lower levels of aldosterone and incidence of cardiovascular disease (CVD). However, the degree to which aldosterone mediates the association between ICH and CVD incidence has not been explored. Thus, we investigated the mediational role of aldosterone in the association of 5 components of ICH (cholesterol, body mass index (BMI), physical activity, diet and smoking) with incident CVD and the mediational role of blood pressure (BP) and glucose in the association of aldosterone with incident CVD in a cohort of African Americans (AA).

Methods:

The Jackson Heart Study is a prospective cohort of AAs adults with data on CVD outcomes. Aldosterone, ICH metrics and baseline characteristics were collected at exam 1 (2000-2004). ICH score was developed by summing 5 ICH metrics (smoking, dietary intake, physical activity, BMI, and total cholesterol) and grouped into two categories (0-2 and ≥3 metrics). Incident CVD was defined as stroke, coronary heart disease, or heart failure. Cox proportional hazard regression models were used to model the association of categorical ICH score with incident CVD. The R Package Mediation was utilized to examine 1) The mediational role of aldosterone in the association of ICH with incident CVD and 2) The mediational role of blood pressure and glucose in the association of aldosterone with incident CVD.

Results:

Among 3,274 individuals (mean age 54±12.4 years, 65% female), there were 368 cases of incident CVD over a median of 12.7 years. The risk of incident CVD was 46% lower (HR 0.54; 95%CI 0.36, 0.80) in those with ≥3 ICH metrics at baseline compared to 0-2. Aldosterone mediated 5.4% (p = 0.006) of the effect of ICH on incident CVD. A 1-unit increase in log-aldosterone was associated with a 38% higher risk of incident CVD (HR 1.38, 95%CI 1.19, 1.61) with BP and glucose mediating 25.6% (p<0.001) and 4.8% (p = 0.048), respectively.

Conclusion:

Aldosterone partially mediates the association of ICH with incident CVD and both blood pressure and glucose partially mediate the association of aldosterone with incident CVD, emphasizing the potential importance of aldosterone and ICH in risk of CVD among AAs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
...